EHC/X
Oct 17, 2025, 08:28
EHC New Tech 2025: Join to Explore Advances in Bleeding Disorders Treatments
The European Haemophilia Consortium (EHC) shared on X:
”Just two weeks to the EHC New Tech 2025!
Join us on Oct 31–Nov 2 in Ljubljana to explore advances in Bleeding Disorders treatments.
Limited to EHC NMOs and HCPs—secure your spot!”
New products for bleeding disorders are expected to enter the European market in the future.
EHC New Tech 2025 will explore the underlying technologies of these innovations and examine strategies to ensure patient access—particularly focusing on their economic sustainability.
Don’t miss it! Register here.
Stay updated with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis